Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxigesic injection for post-operative analgesia after laparoscopic or robotic urologic surgery
KCT0011156Phase 4Not yet recruiting
- Sponsor
- Kyongbo Pharm
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of acetaminophen + ibuprofen in postoperative pain (2 arms), sponsored by Kyongbo Pharm. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on KCT0011156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011156.